Literature DB >> 11422788

Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour.

T Kimoto1, K Hino, S Koya-Miyata, Y Yamamoto, M Takeuchi, Y Nishizaki, M J Micallef, S Ushio, K Iwaki, M Ikeda, M Kurimoto.   

Abstract

Tryptanthrin, a bioactive ingredient of Polygonum tinctorium Lour., is a member of the Indigo plant family and has potent cytocidal effects on various human leukemia cells in vitro. At low concentrations, tryptanthrin enhanced the expression of cell differentiation (CD) markers in human monocytic (U-937) and promyelocytic (HL-60) leukemia cells indicative of differentiation to monocytes/macrophages. Furthermore, nitroblue tetrazolium (NBT) reductive and alpha-naphthyl butyrate esterase (NBE) activities were markedly increased after treatment. Tryptanthrin was more potent than dimethyl sulfoxide (DMSO) at inducing U-937 cell differentiation into monocytes/macrophages. After treatment with higher concentrations of tryptanthrin for 24 h, cytoplasmic vacuolation and destruction of mitochondria were observed. The leukemia cells died via apoptosis 48 h after treatment. Cytoplasmic vacuolation and apoptotic changes correlated with the dysfunction of mitochondria. Electron microscopic observations revealed marked swelling and destruction of mitochondria after exposure of the leukemia cells to tryptanthrin. Exposure to tryptanthrin enhanced Fas-induced apoptosis and increased caspase-3 activity before induction of apoptosis. These results show that low concentrations of tryptanthrin can induce differentiation of leukemia cells but higher concentrations will kill leukemia cells through apoptosis, possibly through a caspase-3/Fas antigen pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422788     DOI: 10.1046/j.1440-1827.2001.01204.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  14 in total

1.  Kourokhitin, a potential drug containing two active substances.

Authors:  A M Popov; Yu M Gafurov; T V Moskovkina; A V Kachanov; O N Krivoshapko; S E Petrovicheva; V A Stonik
Journal:  Dokl Biochem Biophys       Date:  2009 May-Jun       Impact factor: 0.788

Review 2.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

3.  Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines.

Authors:  Sung-tsai Yu; Ji-wang Chern; Tzer-ming Chen; Yi-fan Chiu; Hui-ting Chen; Yen-hui Chen
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

4.  Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Andrei S Potapov; Anastasia R Kovrizhina; Vladislava V Matveevskaya; Maxim L Belyanin; Dmitriy N Atochin; Svitlana O Zanoza; Nadiya M Gaidarzhy; Sergiy A Lyakhov; Liliya N Kirpotina; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2018-10-12       Impact factor: 6.514

5.  Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway.

Authors:  Xuemei Liao; Xuelin Zhou; Nai-ki Mak; Kwok-nam Leung
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

6.  The synthetic tryptanthrin analogue suppresses STAT3 signaling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells.

Authors:  Anup S Pathania; Suresh Kumar; Santosh K Guru; Shashi Bhushan; Parduman R Sharma; Sravan K Aithagani; Parvinder P Singh; Ram A Vishwakarma; Ajay Kumar; Fayaz Malik
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

7.  Tryptanthrin Suppresses the Activation of the LPS-Treated BV2 Microglial Cell Line via Nrf2/HO-1 Antioxidant Signaling.

Authors:  Young-Won Kwon; So Yeong Cheon; Sung Yun Park; Juhyun Song; Ju-Hee Lee
Journal:  Front Cell Neurosci       Date:  2017-02-02       Impact factor: 5.505

8.  Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative.

Authors:  Alexander Popov; Anna Klimovich; Olga Styshova; Taisiya Moskovkina; Andrey Shchekotikhin; Natalia Grammatikova; Lyubov Dezhenkova; Dmitry Kaluzhny; Peter Deriabin; Andrey Gerasimenko; Anatoly Udovenko; Valentin Stonik
Journal:  Int J Mol Med       Date:  2020-08-06       Impact factor: 4.101

9.  Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63.

Authors:  Yu-Chi Tsai; Chia-Lin Lee; Hung-Rong Yen; Young-Sheng Chang; Yu-Ping Lin; Su-Hua Huang; Cheng-Wen Lin
Journal:  Biomolecules       Date:  2020-02-27

10.  Inhibiting eukaryotic ribosome biogenesis.

Authors:  Dominik Awad; Michael Prattes; Lisa Kofler; Ingrid Rössler; Mathias Loibl; Melanie Pertl; Gertrude Zisser; Heimo Wolinski; Brigitte Pertschy; Helmut Bergler
Journal:  BMC Biol       Date:  2019-06-10       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.